Osteoprotegerin (TNFRSF11B) Human shRNA Plasmid Kit (Locus ID 4982)
CAT#: TR308738
TNFRSF11B - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | Osteoprotegerin (TNFRSF11B) Human shRNA Plasmid Kit (Locus ID 4982) |
Locus ID | 4982 |
UniProt ID | O00300 |
Synonyms | OCIF; OPG; PDB5; TR1 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | TNFRSF11B - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 4982). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | BC030155, NM_002546, NM_002546.1, NM_002546.2, NM_002546.3, BC011023, BM748946, NM_002546.4 |
Summary | The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein is an osteoblast-secreted decoy receptor that functions as a negative regulator of bone resorption. This protein specifically binds to its ligand, osteoprotegerin ligand, both of which are key extracellular regulators of osteoclast development. Studies of the mouse counterpart also suggest that this protein and its ligand play a role in lymph-node organogenesis and vascular calcification. Alternatively spliced transcript variants of this gene have been reported, but their full length nature has not been determined. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Esophageal cancer cells convert the death signal from TRAIL into a stimulus for survival during acid/bile exposure
,Chang, Z;Dang, T;Che, N;Yu, H;Chai, J;Chen, W;,
Digestive and Liver Disease
,PubMed ID 32505571
[TNFRSF11B]
|
Documents
Product Manuals |
FAQs |
SDS |
其它TNFRSF11B产品
Customer
Reviews
Loading...